Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults
接种 1 剂或 2 剂 rVSVΔG-ZEBOV-GP 埃博拉疫苗 (ERVEBO®) 后的免疫原性和疫苗脱落情况:一项针对儿童和成人的 2 期随机、安慰剂对照试验的结果
期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciad693
Lee, Andrew W; Liu, Ken; Lhomme, Edouard; Blie, Julie; McCullough, John; Onorato, Matthew T; Connor, Laurie; Simon, Jakub K; Dubey, Sheri; VanRheenen, Susan; Deutsch, Jonathan; Owens, Abigail; Morgan, Amy; Welebob, Carolee; Hyatt, Donna; Nair, Sunita; Hamzé, Benjamin; Guindo, Oumar; Sow, Samba O; Beavogui, Abdoul H; Leigh, Bailah; Samai, Mohamed; Akoo, Pauline; Serry-Bangura, Alimamy; Fleck, Suzanne; Secka, Fatou; Lowe, Brett; Watson-Jones, Deborah; Roy, Céline; Hensley, Lisa E; Kieh, Mark; Coller, Beth-Ann G